Overview

Seattle Cancer Care Alliance (SCCA) is a Center of Excellence¹ for the diagnosis and treatment of patients with myelodysplastic syndrome (MDS) or myeloproliferative disorders (also called myeloproliferative neoplasms, or MPN), a group of chronic bone marrow diseases that affect blood-forming stem cells.

The physicians and scientists at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center (FHCRC) and UW Medicine, are world leaders in research to better understand the causes of these diseases and provide effective treatments.

SCCA offers a full range of standard therapies, such as the growth factor erythropoietin, which may increase red blood cell counts, and the drugs azacitidine (Vidaza) and decitabine (Dacogen). In addition, we offer treatments that are not yet commercially available but have shown promise in pilot studies and are being tested in clinical trials, such as clofarabine (given by mouth), SB1518 (a tyrosine kinase inhibitor) and others.

We also offer bone marrow (stem cell) transplantation (also called hematopoietic cell transplantation) the only treatment option with the potential to cure MDS or MPN. SCCA ranked ranked first in outcomes in a five-year study by the National Marrow Donor Program that measured one-year survival rates of patients among 122 transplant centers in the United States.

¹As recognized by the Myelodysplastic Syndromes Foundation

Myeloproliferative Neoplasms (MPN) Facts

Learn about the risk factors and symptoms of Myeloproliferative Neoplasms (MPN), how it is diagnosed and how its stages are determined.

Treatment Options

Regardless of the stage of your illness, the unsurpassed expertise of our physicians makes SCCA the ideal treatment center for Myeloproliferative Neoplasms (MPN).

Our Doctors

Our doctors are members of Fred Hutchinson Cancer Research Center and faculty from UW Medicine and Seattle Children's. They are the best of the best who work as a team to care for people with Myeloproliferative Neoplasms (MPN)

Participate in a Study

As a world-class treatment center, SCCA provides patients with the best and most current therapies available. Clinical studies bring promising new treatments to patients faster. And participating in a study gives patients at least the best, current treatment, as well as the satisfaction that they are helping others with Myeloproliferative Neoplasms (MPN).

Patient Support

Because treatment for Myeloproliferative Neoplasms (MPN) isn't easy, special support for patients is essential. SCCA has several programs, classes, and services to assist patients and their families.

Web Resources

The more you know about your disease, the more empowered you'll feel. This list of reputable sources about Myeloproliferative Neoplasms (MPN) makes gathering information easy.

Myeloproliferative Neoplasms (MPN)